We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Re-Inspection Clears Akorn’s Facility in Illinois for Production
FDA Re-Inspection Clears Akorn’s Facility in Illinois for Production
FDA investigators have cleared Akorn’s facility in Illinois for production, following a re-inspection that confirmed the company corrected several GMP deficiencies.